ArticleThe Journal of biological chemistry2026
Full-length tau seeded by C-shaped tau fibrils is conformationally variable.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From seeds to symptoms: the molecular landscape of tau seeding in Alzheimer's disease.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of neurodegenerative amyloid proteins have been found to adopt disease-specific structures in the human brain. This prion-like propagation of the amyloid structure requires recruitment of soluble monomers containing various posttranslational modifications to adopt the same structure as the fibril seeds. To understand the structural fidelity of seeding for amyloid proteins that possess large intrinsically disordered regions, here we investigate the seeding of a full-length phospho-mimetic tau protein, 4E tau, using a truncated tau construct that adopts the C-shaped Alzheimer's disease (AD) fold. Sedimentation gels indicate that four replicas of cross-seeded reactions all showed accelerated fibrillization kinetics. However, solid-state NMR spectra indicate that these cross-seeded samples have structurally variable cores, all of which differ from the AD fold of the seed fibrils, some of which resemble the unseeded triple-stranded structure of the full-length protein, and two of which contain two polymorphs. INEPT NMR spectra indicate that these cross-seeded replicas have similar dynamic disorder for their fuzzy coat, which differs from the dynamics of unseeded full-length 4E tau. These results indicate that accelerated fibrillization kinetics do not necessarily correlate with faithful amplification of the seed structure, and surface-catalyzed nucleation of full-length tau with large intrinsically disordered regions leads to structural polymorphism and structural evolution from the seed fibrils.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.